2006Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

A Controlled Study of Mirtazapine and Amitrptyline in Somatization

Zhao Hong

Open publisher page 1 citations

Abstract

OBJECTIVE:To compare curative effects, adverse reactions and the safety of mirtazapine and amitriptyline in the treatment of obsession . METHODS:60 patients with somatization disorder were randomly divided into study group (n=30, took mirtazapine) and control group (n=30, took amitriptyline).Curative effects were evaluated with SCL-90 before and at the end of treatment ,at the 2nd, fourth and eighth week of treatment,respectively. Adverse reactions were evaluated with TESS. RESULTS: Curative effects of mirtazapine and amitriptyline were 93.3% and 90% respectively, there was no significant difference(P0.05). Adverse reactions of the former were significantly fewer than that of the latter (P0.01), and it also had good tolerance. CONCLUSION: Curative effect of mirtazapine is correspond to that of amitriptyline, but adverse reactions are fewer. Mirtazapine is a safe and effective new antidepressant.

About this research paper

What this paper is about

OBJECTIVE:To compare curative effects, adverse reactions and the safety of mirtazapine and amitriptyline in the treatment of obsession . METHODS:60 patients with somatization disorder were randomly divided into study group (n=30, took mirtazapine) and control group (n=30, took amitriptyline).Curative effects were evaluated with SCL-90 before and at the end of treatment ,at the 2nd, fourth and eighth week of treatment,respectively. Adverse reactions were evaluated with TESS. RESULTS: Curative effects of mirtazapine and amitriptyline were 93.3% and 90% respectively, there was no significant difference(P0.05). Adverse reactions of the former were significantly fewer than that of the latter (P0.01), and it also had good tolerance. CONCLUSION: Curative effect of mirtazapine is correspond to that of amitriptyline, but adverse reactions are fewer. Mirtazapine is a safe and effective new antidepressant.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To compare curative effects, adverse reactions and the safety of mirtazapine and amitriptyline in the treatment of obsession . METHODS:60 patients with somatization disorder were randomly divided into study group (n=30, took mirtazapine) and control group (n=30, took amitriptyline).Curative effects were evaluated with SCL-90 before and at the end of treatment ,at the 2nd, fourth and eighth week of treatment,respectively. Adverse reactions were evaluated with TESS. RESULTS: Curative effects of mirtazapine and amitriptyline were 93.3% and 90% respectively, there was no significant difference(P0.05). Adverse reactions of the former were significantly fewer than that of the latter (P0.01), and it also had good tolerance. CONCLUSION: Curative effect of mirtazapine is correspond to that of amitriptyline, but adverse reactions are fewer. Mirtazapine is a safe and effective new antidepressant.

Key concepts: Mirtazapine, Amitriptyline, Somatization, Adverse effect, Somatization disorder, Antidepressant, Medicine, Significant difference

Related papers

Back to paper searchBrowse research topicsOriginal source
A Controlled Study of Mirtazapine and Amitrptyline in Somatization — Research Paper | ScholarLens